The failure of the current pharmaceutical research and development (R) system is revealed by the World Health Organization (WHO) alert about the lack of effective medicines to address antimicrobial resistance, and the absence of a treatment for the deadly Ebola virus that is ravaging communities in West Africa at the time of writing.
Topic:
Health, International Trade and Finance, and Health Care Policy
Access to medicines at affordable prices is critical to the enjoyment of the human right to health. Lower prices require the implementation of pro-access policies that include the promotion of generic competition. However, medicines cannot be selected on the basis of price alone. To ensure that only safe, effective, and quality products are on the market, effective regulation is necessary.
Access to medicines poses a critical challenge in developing countries, largely because prices are high, and new or adapted medicines and vaccines to address diseases of the developing world are lacking. More than 5 million people in low and middle income countries still lack access to the anti-retroviral medicines needed to treat HIV and AIDS. Non-communicable diseases (NCDs) have unleashed a new epidemic of suffering across the developing world. Pandemics are a serious threat in rich and poor countries alike, but while rich countries can stockpile medicines, these are often unaffordable for poor countries. Most people in developing countries pay for medicines out-of-pocket, so even a slight price increase can mean that life-saving medicines are unaffordable.
Developing-country governments desperately need more long-term and predictable aid, given through their budgets, to finance the expansion of health care, education, and other vital social services. The European Commission (EC) is one of the biggest donors providing this kind of essential budget support, and has innovative plans to further improve and increase this aid. European Union (EU) member states must support these ambitious plans. The EC in turn must do more to improve on this good start, delinking this aid from harmful International Monetary Fund (IMF) prescriptions, putting an end to unnecessary bureaucratic delays, and doing more to make its aid accountable to citizens in poor countries.
Poverty and suffering could be ended in our lifetime, and our leaders must do everything in their power to make this happen. This was the clear demand of the 40 million people in 36 countries who took part in the Global Call to Action Against Poverty in 2005. A year later, in the space of just one day, 24 million people across the world stood up against poverty as part of World Poverty Day.
Topic:
Education, Health, and Poverty
Political Geography:
Russia, United States, Japan, United Kingdom, Europe, Canada, Asia, France, Germany, and Italy
When the Euro-Mediterranean Partnership (Euro-Med) was announced in Barcelona with a great fanfare in 1995, it was hoped that it would herald a new age in relations between the European Union (EU) and its ten southern Mediterranean partner countries, bringing unprecedented opportunities in the social, economic, and political fields.
Topic:
International Relations, Health, and Human Welfare